Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease
Keun Ho Park(Chosun University), Doo‐Il Kim(Inje University Haeundae Paik Hospital), Do Hoi Kim(Soonchunhyang University Hospital Seoul), Kook Jin Chun(Pusan National University Yangsan Hospital), Young-Jae Ki(Chosun University Hospital), Seok Kyu Oh(Wonkwang University), Tae‐Hyun Yang(Inje University Busan Paik Hospital), Jae Kean Ryu(Lodestar Research Corporation (United States)), Hyun Kuk Kim(Seoul National University Hospital), Jong‐Seon Park(Korea University Medical Center), Seung‐Ho Hur(Keimyung University Dongsan Medical Center), Jay Young Rhew(Presbyterian Medical Center), Dong‐Hyun Choi(Chosun University Hospital), Jin‐Yong Hwang(Chonnam National University), Sang Gon Lee(Yong In University), Youngkeun Ahn(Chonnam National University Hospital), Hun Sik Park(Kyungpook National University Hospital), Sung Soo Kim(Chonnam National University Hospital), Young-Youp Koh(Chosun University Hospital), Young Joon Hong(Chonnam National University Hospital), Sun Ho Hwang(Veterans Health Service Medical Center), Seung-Uk Lee(Kwangju Christian Hospital), Jang-Hyun Cho, Bong Ryeol Lee(Daegu Fatima Hospital), Tae‐Ho Park(Dong-A University Hospital), Kwang Soo, Jei Keon Chae(Chonnam National University)
Cited by 23
Related Papers
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
|New England Journal of Medicine|2011|683
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
|New England Journal of Medicine|2015|505